Skip to main content

DUBLIN–(BUSINESS WIRE)–The report “Clinical Research Services Market Research Report by Services, By Indication, By Deployment, By End User, By Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” was added to from offer.

The global clinical research services market size was estimated at USD 44.07 billion in 2020, is projected to reach USD 48.01 billion in 2021 and is projected to grow at a CAGR of 9.31% to reach USD 82.19 billion. 2027.

Competitive Strategy Window:

The strategic competitive window analyzes the competitive landscape in terms of markets, applications and geographies to help the vendor define an alignment or match between its capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for vendors to adopt successive strategies of merger and acquisition, geographic expansion, research and development, and new product introduction strategies to execute further business expansion and growth. during a forecast period.

FPNV positioning matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Clinical Research Services Market based on business strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Customer Satisfaction. product (value for money, ease of use, product features and customer). Support) that helps businesses make better decisions and understand the competitive landscape.

Market share analysis:

The market share analysis offers the analysis of the vendors considering their contribution to the overall market. It gives the idea of ​​its revenue generation in the overall market compared to other providers in the space. It provides information on the performance of vendors in terms of revenue generation and customer base compared to others. Knowing the market share gives an idea of ​​the size and competitiveness of suppliers for the reference year. It reveals the characteristics of the market in terms of accumulation, fragmentation, dominance and merger.

The report provides information about the following pointers:

1. Market Penetration: Provides comprehensive information about the market offered by major players

2. Market Development: Provides detailed information on lucrative emerging markets and analyzes penetration in mature market segments

3. Market Diversification: Provides detailed information on new product launches, untapped geographies, recent developments and investments

4. Competitive Assessment and Intelligence: Provides a comprehensive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of key players

5. Product Development and Innovation: Provides smart insights into future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the global clinical research services market?

2. What are the inhibiting factors and impact of COVID-19 on the global clinical research services market during the forecast period?

3. What are the products/segments/applications/areas to invest in during the forecast period in the Global Clinical Research Services Market?

4. What is the competitive strategic window for opportunities in the Global Clinical Research Services Market?

5. What are the technology trends and regulatory frameworks in the global clinical research services market?

6. What is the market share of the major vendors in the global clinical research services market?

7. What modes and strategic moves are considered suitable for entering the global clinical research services market?

Market dynamics


  • Rapid technological advancements and increasing globalization are encouraging biotech and pharmaceutical companies

  • Demand for Effective Medicines and Health Devices

  • Increase in patient population


  • High cost associated with product development


  • Increase investment in research and development activities

  • Develop strategic collaboration between companies


  • Rigorous drug approval process

Companies cited

  • Acculab Life Sciences

  • America Holdings

  • fiery CRO

  • Axcent Advanced Analytics (A3)

  • Azelix

  • Therapeutic BIO Agile

  • Charles River International Laboratories Inc.

  • Covance Inc.



  • Dove quality solutions

  • Clinical Research Firma

  • Fisher Clinical Services, Inc.



  • LabCorp

  • Medspace Holdings

  • Parexel International Corporation


  • Pharmaceutical Product Development, LLC

  • PRA Health Sciences


  • SGS S.A.

  • Syneos Health

  • Wuxi AppTec Inc.

For more information about this report visit